Zhang Lei portfolio, Q2 2025
HHLR Advisors (Hillhouse) · 13F for the quarter ending Jun 30, 2025
For Q2 2025, HHLR Advisors (Hillhouse) reported $3.1B across 36 US-listed positions, led by PDD (23.5%), FUTU (17.2%) and BULL (12.7%). Compared with its filing for Q1 2025, Zhang Lei opened 2 new positions, added to 2, reduced 9 and sold out of 15; 23 positions did not change.
The largest purchase was a new position in BULL ($395.6M); the largest sale, a reduction of BABA ($312.8M).
Key facts
- 13F portfolio value
- $3.1BQ2 2025
- Positions
- 36
- Largest holding
- PDD 23.5%
- New positions
- 2
- Sold out
- 15
- Filed
- Aug 14, 2025
Holdings as of (Q2 2025), filed with the SEC on . Changes are measured against the filing for Mar 31, 2025. Every tracked investor's Q2 2025 13F.
Bought and sold in Q2 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| Webull CorpBULL | ▲ New | +33.08M | $395.6M | 12.7% |
| Alibaba Group Holding LtdBABA | ▼ Reduced 71% | −2.76M | $312.8M | 10.1% |
| NetEase IncNTES | ▼ Reduced 38% | −1.01M | $135.3M | 4.36% |
| Vipshop Holdings LtdVIPS | ▼ Reduced 83% | −5.55M | $83.6M | 2.69% |
| JD.com IncJD | ▼ Reduced 53% | −2.54M | $82.8M | 2.67% |
| KE Holdings IncBEKE | ▼ Reduced 38% | −4.51M | $80M | 2.58% |
| Trip.com Group LtdTCOM | ▼ Sold out | −938.84K | $59.7M | 1.92% |
Enfusion Incno ticker on file | ▼ Sold out | −4.98M | $55.5M | 1.79% |
| PDD Holdings IncPDD | ▲ Added 6.3% | +414.23K | $43.4M | 1.40% |
Clearwater Analytics Holdingsno ticker on file | ▲ New | +1.37M | $30M | 0.96% |
| Baidu IncBIDU | ▼ Sold out | −170K | $15.6M | 0.50% |
| Yum China Holdings IncYUMC | ▼ Sold out | −292.12K | $15.2M | 0.49% |
| H World Group LtdHTHT | ▼ Sold out | −237.33K | $8.8M | 0.28% |
| Yatsen Holding LtdYSG | ▼ Reduced 11% | −773.94K | $7.5M | 0.24% |
| Atour Lifestyle Holdings LtdATAT | ▼ Sold out | −242.34K | $6.9M | 0.22% |
| Taiwan Semiconductor Manufacturing Company LtdTSM | ▼ Sold out | −33K | $5.5M | 0.18% |
| Sohu.com LtdSOHU | ▼ Sold out | −201.43K | $2.7M | 0.09% |
| Danaher CorpDHR | ▼ Sold out | −8.03K | $1.6M | 0.05% |
| JOYY IncJOYY | ▼ Sold out | −34K | $1.4M | 0.05% |
| China Yuchai International LtdCYD | ▼ Sold out | −70K | $1.2M | 0.04% |
| Weibo CorpWB | ▼ Sold out | −100K | $947K | 0.03% |
| X FinancialXYF | ▼ Sold out | −50K | $719.5K | 0.02% |
| Futu Holdings LtdFUTU | ▲ Added 0.1% | +4.75K | $586.4K | 0.02% |
| Ecarx Holdings IncECX | ▼ Sold out | −400K | $504K | 0.02% |
| Metagenomi IncMGX | ▼ Sold out | −150.7K | $205K | 0.01% |
| GE AerospaceGE | ▼ Reduced 6.7% | −452 | $116.3K | 0.00% |
| Moodys CorpMCO | ▼ Reduced 6.1% | −161 | $80.8K | 0.00% |
| MSCI IncMSCI | ▼ Reduced 5.6% | −120 | $69.2K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | PDD Holdings IncPDD · SPONSORED ADS | Consumer Discretionary | 23.5% | $730.2M | 6.98M | $104.66 | 5+ qtrs | ▲ Added 6.3% |
| 2 | Futu Holdings LtdFUTU · SPON ADS CL A | Financials | 17.2% | $532.9M | 4.31M | $123.59 | 5+ qtrs | ▲ Added 0.1% |
| 3 | Webull CorpBULL · ORD SHS | — | 12.7% | $395.6M | 33.08M | $11.96 | 1 qtr | New |
| 4 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 8.07% | $250.4M | 1.03M | $242.07 | 5+ qtrs | No change |
| 5 | NetEase IncNTES · SPONSORED ADS | Technology | 7.21% | $223.9M | 1.66M | $134.58 | 5+ qtrs | ▼ Reduced 38% |
| 6 | Legend Biotech CorpLEGN · SPONSORED ADS | Health Care | 6.84% | $212.4M | 5.98M | $35.49 | 5+ qtrs | No change |
| 7 | KE Holdings IncBEKE · SPONSORED ADS | Real Estate | 4.27% | $132.4M | 7.47M | $17.74 | 5+ qtrs | ▼ Reduced 38% |
| 8 | Alibaba Group Holding LtdBABA · SPONSORED ADS | Consumer Discretionary | 4.20% | $130.4M | 1.15M | $113.41 | 5+ qtrs | ▼ Reduced 71% |
| 9 | Arrivent Biopharma IncAVBP | — | 3.15% | $97.6M | 4.48M | $21.77 | 5+ qtrs | No change |
| 10 | WNS Holdings Ltdno ticker on file | — | 3.12% | $96.8M | 1.53M | $63.24 | 3 qtrs | No change |
| 11 | JD.com IncJD · SPON ADS CL A | Consumer Discretionary | 2.39% | $74.3M | 2.28M | $32.64 | 5+ qtrs | ▼ Reduced 53% |
| 12 | Yatsen Holding LtdYSG · SPONSORED ADS | — | 1.90% | $58.9M | 6.11M | $9.64 | 5+ qtrs | ▼ Reduced 11% |
| 13 | Clearwater Analytics Holdingsno ticker on file · CL A | — | 0.97% | $30M | 1.37M | $21.93 | 1 qtr | New |
| 14 | Cytek Biosciences IncCTKB | — | 0.73% | $22.6M | 6.66M | $3.40 | 5+ qtrs | No change |
| 15 | Vipshop Holdings LtdVIPS · SPONSORED ADS A | Consumer Discretionary | 0.55% | $17M | 1.13M | $15.05 | 5+ qtrs | ▼ Reduced 83% |
| 16 | LI Auto IncLI · SPONSORED ADS | Consumer Discretionary | 0.54% | $16.8M | 620K | $27.11 | 2 qtrs | No change |
| 17 | Novabridge BiosciencesNBP · SPONSORED ADS | — | 0.47% | $14.5M | 5.98M | $2.42 | 5+ qtrs | No change |
| 18 | Zto Express Cayman IncZTO · SPONSORED ADS A | Industrials | 0.38% | $11.9M | 671.39K | $17.75 | 5+ qtrs | No change |
| 19 | Kanzhun LimitedBZ · SPONSORED ADS | Technology | 0.33% | $10.3M | 576.34K | $17.84 | 2 qtrs | No change |
| 20 | Agora IncAPI · ADS | — | 0.26% | $8M | 2.1M | $3.81 | 3 qtrs | No change |
| 21 | Gossamer Bio IncGOSS | — | 0.20% | $6.1M | 4.97M | $1.23 | 5+ qtrs | No change |
| 22 | Maze Therapeutics IncMAZE | — | 0.18% | $5.6M | 457.54K | $12.27 | 2 qtrs | No change |
| 23 | Sagimet Biosciences IncSGMT | — | 0.18% | $5.5M | 724.8K | $7.62 | 5+ qtrs | No change |
| 24 | Smart SH Global Ltdno ticker on file · ADS | — | 0.15% | $4.5M | 3.95M | $1.14 | 5+ qtrs | No change |
| 25 | Tuya IncTUYA · SPONSERED ADS | — | 0.12% | $3.6M | 1.56M | $2.31 | 5+ qtrs | No change |
| 26 | Contineum Therapeutics IncCTNM · CL A | — | 0.09% | $2.7M | 669.34K | $3.97 | 5+ qtrs | No change |
| 27 | Mogu IncMOGU · SPON ADS | — | 0.06% | $1.8M | 847.51K | $2.13 | 5+ qtrs | No change |
| 28 | Bright Scholar ED Holdings Ltdno ticker on file · SPON ADS NEW | — | 0.06% | $1.7M | 988.14K | $1.77 | 5+ qtrs | No change |
| 29 | GE AerospaceGE | Industrials | 0.05% | $1.6M | 6.31K | $257.39 | 5+ qtrs | ▼ Reduced 6.7% |
| 30 | Moodys CorpMCO | Financials | 0.04% | $1.2M | 2.48K | $501.59 | 5+ qtrs | ▼ Reduced 6.1% |
| 31 | MSCI IncMSCI | Financials | 0.04% | $1.2M | 2.01K | $576.74 | 3 qtrs | ▼ Reduced 5.6% |
| 32 | Pacific Biosciences of California IncPACB | — | 0.04% | $1.1M | 918.89K | $1.24 | 5+ qtrs | No change |
| 33 | Aligos Therapeutics IncALGS | — | 0.02% | $549.7K | 76.25K | $7.21 | 5+ qtrs | No change |
| 34 | Lakeshore Biopharma Co Ltdno ticker on file · ORD SHS NEW | — | 0.00% | $76.7K | 75.18K | $1.02 | 3 qtrs | No change |
| 35 | Uxin LtdUXIN · SPONSORED ADS | — | 0.00% | $70.5K | 19.16K | $3.68 | 5+ qtrs | No change |
| 36 | Ridgetech IncRDGT · SHS NEW | — | 0.00% | $22.2K | 20.17K | $1.10 | 5+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Consumer Discretionary | 31.2% | $968.7M | 5 |
| Financials | 17.2% | $535.3M | 3 |
| Health Care | 14.9% | $462.8M | 2 |
| Technology | 7.54% | $234.2M | 2 |
| Real Estate | 4.27% | $132.4M | 1 |
| Industrials | 0.44% | $13.5M | 2 |
| No sector on file | 24.4% | $757.5M | 21 |
Questions and answers
What did Zhang Lei own in Q2 2025?
HHLR Advisors (Hillhouse)'s 13F for Q2 2025 lists 36 positions worth $3.1B. The largest: PDD (23.5%), FUTU (17.2%), BULL (12.7%), ONC (8.1%), NTES (7.2%).
What did Zhang Lei buy in Q2 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: BULL (new, $395.6M), PDD (added, $43.4M), Clearwater Analytics Holdings (new, $30M), FUTU (added, $586.4K).
What did Zhang Lei sell in Q2 2025?
The largest sales: BABA (reduced, $312.8M), NTES (reduced, $135.3M), VIPS (reduced, $83.6M), JD (reduced, $82.8M), BEKE (reduced, $80M), TCOM (sold out, $59.7M).
When was this filing made?
HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Jun 30, 2025 on Aug 14, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Zhang Lei portfolio, Q2 2025: HHLR Advisors (Hillhouse) 13F holdings”, data as of 14 August 2025. https://funkfolio.com/gurus/hillhouse/2025-q2
Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Jun 30, 2025.
Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Jun 30, 2025, filed Aug 14, 2025. Changes compare share counts with the filing for Mar 31, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $3.1B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 5 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.